ReviewTNF-α signaling in Fanconi anemia☆
Introduction
Fanconi anemia (FA) is a rare inherited disease associated with bone marrow failure (BMF), variable congenital/developmental abnormalities, and cancer susceptibility [1], [2], [3]. Approximately 1000 persons worldwide currently suffer from the disease, 10 to 20 children are born with FA in the United States each year [1]. It is genetically heterogeneous, with 16 complementation groups identified thus far [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22]. The genes encoding the groups A (FANCA), B (FANCB), C (FANCC), D1 (FANCD1/BRCA2), D2 (FANCD2), E (FANCE), F (FANCF), G (FANCG), I (FANCI/KIAA1794), J (FANCJ/BRIP1), L (FANCL), M (FANCM), N (FANCN/PALB2), O (FANCO/RAD51C), P (FANCP/SLX4) and Q (FANCQ/ERCC4/XPF) proteins have been cloned ([4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], Table 1), of which FANCA, FANCG and FANCC are the most commonly mutated genes in FA populations ([2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], Fig. 1). At the cellular level, FA is characterized by chromosomal instability and cross-linker sensitivity, which serves as a clinical diagnostic hallmark of FA [1], [3]. Strong evidence indicates that the products of all of the FA genes function together in the FA pathway. In fact, the prominent role of the FA pathway has been implicated in DNA damage response and/or repair (DDR) [27].
Section snippets
Multifunctionality of FA proteins
Intense studies have been focusing on biological function of FA proteins. Compelling evidence suggested that eight of the FA proteins (namely, FANCA, B, C, E, F, G, L, and M) and 6 associated factors (FAAP100, FAAP24, FAAP20, HES1, MHF1 and MHF2) form a nuclear multiprotein complex, which is required for the efficient mono-ubiquitination of downstream FANCD2/FANCI dimer in response to DNA damage or DNA replication stress [2], [8], [9], [12], [18], [28], [29], [30], [31], [32], [33], [34], [35],
Hematopoietic failure and abnormal apoptotic signaling in FA
The most common clinical features of FA are hematological. A majority of children with FA invariably experience pancytopenia during the first few years of life, which is associated with stem cell loss in the hematopoietic compartment. Complications of bone marrow failure (BMF) are the major causes of morbidity and mortality of FA [1], [44], [45], [46], [47], [48]. In addition, rapid hematopoietic cell loss forces compensatory chronic proliferation, which may lead to leukemogenesis [14], [49],
The link between pro-inflammatory cytokine TNF-α, inflammation and diseases
TNF-α is a proinflammatory cytokine produced by multiple immune and non-immune cells, including lymphocytes, mast cells, endothelial cells, fibroblasts and adipocytes. It functions in the regulation of diverse physiological cellular events, including cell proliferation, differentiation and apoptosis as well as various inflammatory processes [93], [94]. TNF-α is also involved in pathological actions, such as systematic inflammation and initiation of the acute phase reaction by promoting
TNF-α signaling in pathophysiology
The molecular mechanisms of TNF-α functions have been intensively investigated. It is believed that the biological activities of TNF-α are mediated by two structurally related but functionally distinct receptors, designated as the p55 and p75 TNF-α receptors, TNFR1 and TNFR2, respectively [93]. Binding of TNF-α to the receptors initiates a complex array of signaling events in response to TNF-α receptor activation and gives rise to the pleiotropic effects of TNF-α on cells [107], [108], mainly
The roles of TNF-α in HSC function and leukemic transformation in general
HSC function is regulated by microenvironment directly through cell–cell interactions or indirectly through production of cytokines [155]. Many cytokines and growth factors including TNF-α are known to regulate HSC survival, homing, and proliferation [156]. TNF-α plays a pivotal role in directly regulating HSC proliferation or indirectly stimulating growth factor production and up-regulation of cytokine receptors. While TNF-α induces proliferation of the more primitive subset of progenitors, it
The roles of TNF-α in HSC function and leukemic transformation in FA
Elevated levels of serum, plasma or intracellular TNF-α are often found in patients with FA. The increased secretion of TNF-α along with altered production of other growth factors and cytokines, including reduced expression of interleukin-6 (IL-6) and granulocyte-macrophage colony-stimulating factor, may change the BM microenvironment by leading to factor deprivation or constant exposure to mitogenic inhibitors [26]. These expression alterations may cause deregulation of cellular homeostasis
Therapies targeting inflammatory cytokines in treatment of human diseases including hematologic diseases
Cytokines are a large family of small proteins that function in essentially all biological processes. Abnormalities in cytokine expression, their receptors, and the signaling pathways are involved in variety of diseases, such as immune and inflammatory disorders and cancers [93]. As cytokines are potent rate-limiting extracellular molecules, therapies targeting cytokines by greater surface of interaction of receptors and antibodies with their targets have gained variable successes. For example,
Summary
The pro-inflammatory cytokine, TNF-α has been considered as one important pathological factor involved in the abnormal hematopoiesis most commonly found in BMF diseases including FA, an excellent disease model for studying BMF and leukemogenesis. Although the molecular pathogenesis of FA remains to be elucidated, overproduction of TNF-α in FA most likely plays a dual role. It may act as both a death mediator and a leukemic promoter. Understanding the relationship between inflammation and FA
Conflict of interest
The authors declare no conflict of interest.
References (190)
- et al.
Positional cloning of a novel Fanconi anemia gene, FANCD2
Mol. Cell
(2001) - et al.
Isolation of a cDNA representing the Fanconi anemia complementation group E gene
Am. J. Hum. Genet.
(2000) - et al.
Complementation analysis in Fanconi anemia: assignment of the reference FA-H patient to group A
Am. J. Hum. Genet.
(2000) - et al.
Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia
Am. J. Hum. Genet.
(2013) - et al.
The genetic and molecular basis of Fanconi anemia
Mutat. Res.
(2009) - et al.
Heterogeneity in Fanconi anemia: evidence for two new genetic subtypes
Blood
(2004) - et al.
Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM
Mol. Cell
(2007) - et al.
FANCM and FAAP24 function in ATR-mediated checkpoint signaling independently of the Fanconi anemia core complex
Mol. Cell
(2008) - et al.
MHF1–MHF2, a histone-fold-containing protein complex, participates in the Fanconi anemia pathway via FANCM
Mol. Cell
(2010) - et al.
FAAP20: a novel ubiquitin-binding FA nuclear core-complex protein required for functional integrity of the FA–BRCA DNA repair pathway
Blood
(2012)
HES1 is a novel interactor of the Fanconi anemia core complex
Blood
Is Fanconi anemia caused by a defect in the processing of DNA damage?
Mutat. Res.
Functional correction of FA-C cells with FANCC suppresses the expression of interferon gamma-inducible genes
Blood
A 20-year perspective on the International Fanconi Anemia Registry (IFAR)
Blood
Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor alpha
Blood
TNF-alpha and IFN-gamma are overexpressed in the bone marrow of Fanconi anemia patients and TNF-alpha suppresses erythropoiesis in vitro
Blood
A role for the Fanconi anemia C protein in maintaining the DNA damage-induced G2 checkpoint
J. Biol. Chem.
Therapy-related myelodysplastic syndrome and acute myeloid leukemia in children: correlation between chromosomal abnormalities and prior therapy
Blood
Cytogenetic abnormalities in the myelodysplastic syndromes and occupational or environmental exposure
Blood
Suppression of apoptosis in hematopoietic factor-dependent progenitor cell lines by expression of the FAC gene
Blood
Multiple inhibitory cytokines induce deregulated progenitor growth and apoptosis in hematopoietic cells from Fac −/− mice
Blood
Loss of FancC function results in decreased hematopoietic stem cell repopulating ability
Blood
Retroviral-mediated expression of recombinant Fancc enhances the repopulating ability of Fancc −/− hematopoietic stem cells and decreases the risk of clonal evolution
Blood
The Fanconi anemia group C gene product modulates apoptotic responses to tumor necrosis factor-alpha and Fas ligand but does not suppress expression of receptors of the tumor necrosis factor receptor superfamily
Exp. Hematol.
Continuous in vivo infusion of interferon-gamma (IFN-gamma) preferentially reduces myeloid progenitor numbers and enhances engraftment of syngeneic wild-type cells in Fancc −/− mice
Blood
Hematopoietic stem cells in aplastic anemia
Arch. Med. Res.
NF-kappa B family proteins participate in multiple steps of hematopoiesis through elimination of reactive oxygen species
J. Biol. Chem.
The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality
Blood
The anti-apoptotic function of Hsp70 in the interferon-inducible double-stranded RNA-dependent protein kinase-mediated death signaling pathway requires the Fanconi anemia protein, FANCC
J. Biol. Chem.
Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells
Blood
Continuous in vivo infusion of interferon-gamma (IFN-gamma) enhances engraftment of syngeneic wild-type cells in Fanca −/− and Fancg −/− mice
Blood
Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene
Blood
Disease model: Fanconi anemia
Trends Mol. Med.
Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9
Blood
Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex
Exp. Hematol.
In vitro phenotypic correction of hematopoietic progenitors from Fanconi anemia group A knockout mice
Blood
TLR8-dependent TNF-(alpha) overexpression in Fanconi anemia group C cells
Blood
Loss of the Fanconi anemia group C protein activity results in an inability to activate caspase-3 after ionizing radiation
Biochimie
Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes
Am. J. Pathol.
Tumor necrosis factor
Cancer Lett.
Genetic basis of Fanconi anemia
Curr. Opin. Hematol.
Fanconi anaemia
J. Med. Genet.
The Fanconi anemia/BRCA pathway: new faces in the crowd
Genes Dev.
Cloning of cDNAs for Fanconi's anaemia by functional complementation
Nature
Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA
Nat. Genet.
The Fanconi anaemia group G gene FANCG is identical with XRCC9
Nat. Genet.
The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM
Nat. Genet.
Biallelic inactivation of BRCA2 in Fanconi anemia
Science
A novel ubiquitin ligase is deficient in Fanconi anemia
Nat. Genet.
X-linked inheritance of Fanconi anemia complementation group B
Nat. Genet.
Cited by (47)
Therapeutic research in the crystal chromosome disease Fanconi anemia
2018, Mutation Research - Genetic Toxicology and Environmental MutagenesisMechanistic and biological considerations of oxidatively damaged DNA for helicase-dependent pathways of nucleic acid metabolism
2017, Free Radical Biology and MedicineCitation Excerpt :However, cells from FA individuals are hypersensitive to agents that induce oxidative stress [134] and display elevated oxidatively damaged DNA [135], including 8-oxoG [136], consistent with elevated ROS and mitochondrial dysfunction [137,138]. The elevated ROS in FA is thought to arise from increased circulatory inflammatory cytokines [139,140], which in turn may be stimulated by oxidatively damaged DNA (reviewed in [141]) (Fig. 3). The hematopoietic stem cell attrition characteristic of FA is believed to arise in large part from DNA damage induced by endogenous formaldehyde [142–144].
Tumor necrosis factor α in the onset and progression of leukemia
2017, Experimental HematologyFanconi Anemia: A DNA repair disorder characterized by accelerated decline of the hematopoietic stem cell compartment and other features of aging
2017, Ageing Research ReviewsCitation Excerpt :The designation of FA as a DNA repair disorder, and the recent literature cited above, leads naturally to the inclination to interpret all pathologies as the result of this deficiency. However, the groups of Grover Bagby and Qishen Pang, among others, have argued that the BMF observed in FA children is a consequence of multiple adverse effects provoked by the pro-inflammatory state of FA patients (Bagby, 2003; Du et al., 2014). This view is extended in recent work in which it was shown that DNA damage and repair deficiencies do not explain the over-production of inflammatory cytokines by FA cells (Garbati et al., 2015).
The Treatment of Tubal Inflammatory Infertility using Yinjia Tablets through EGFR/MEK/ERK Signaling Pathway based on Network Pharmacology
2024, Current Pharmaceutical BiotechnologyPolyclonal evolution of Fanconi anemia to MDS and AML revealed at single cell resolution
2022, Experimental Hematology and Oncology
- ☆
The authors are supported by NIH grants R01 HL076712 and R01 CA157537. Q.P. is supported by a Leukemia and Lymphoma Scholar award. W.D. is supported by a NIH T32 grant.